发明名称 NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS
摘要 <p>Compounds of formula (I); wherein R1 and R2 are the same or different and may be selected from the group consisting of a hydrogen atom, a hydroxy group, an alkyl group, a halogen atom, an alkoxy group, an acyloxy group, an acyl group, an alkenyl group, an alkynyl group, an aryl group, an alkylthio group, an alkoxycarbonyl group, an alkylsulfinyl group, an alkylsulfonyl group, an amino group, and an alkylamino group; and X represents a carboxylic acid group, a carboxylate group, or a carboxamide group; or any pharmaceutically acceptable salt, solvate, complex or pro-drug thereof, with the provisos that the compound of formula (I) is not (all-Z)-4,7,10,13,16,19-docosahexaenoic acid (DHA), alpha-methyl-DHA, alpha-methyl DHA methyl ester, alpha-methyl-DHA ethyl ester or alpha-hydroxy DHA ethyl ester, are disclosed. A fatty acid composition and a pharmaceutical composition comprising such compounds are also disclosed. The use of such compounds as medicaments, in particular for the treatment of diabetes type 2, is also disclosed.</p>
申请公布号 EP1888727(B1) 申请公布日期 2015.04.15
申请号 EP20060744648 申请日期 2006.05.04
申请人 PRONOVA BIOPHARMA NORGE AS 发明人 BRYHN, MORTEN;HOLMEIDE, ANNE, KRISTIN;KOPECKY, JAN
分类号 C11C3/00;A61K31/202;A61K31/232;A61K31/421;A61P3/04;A61P3/10;A61P9/10;C07C57/03;C07C69/587;C07D263/24 主分类号 C11C3/00
代理机构 代理人
主权项
地址